Valuation : Cutia Therapeutics

Market Cap 497M 581M 74.14M 64.14M 60.7M 55M 103M 7.08B 103M 721M 277M 3.62B 278M 272M 11.38B P/E 2026 *
-2.99x
P/E 2027 * 10.5x
Enterprise Value 566M 662M 84.39M 73M 69.08M 62.59M 117M 8.06B 118M 821M 315M 4.12B 317M 310M 12.96B EV / Sales 2026 *
0.88x
EV / Sales 2027 * 0.42x
Free-Float
32.66%
Yield 2026 *
-
Yield 2027 * -
1 week-8.31%
Current month-16.23%
1 month-29.52%
3 months-50.31%
6 months-68.69%
Current year-64.76%
1 week 1.51
Extreme 1.51
1.73
1 month 1.51
Extreme 1.51
2.4
Current year 1.51
Extreme 1.51
5.51
1 year 1.51
Extreme 1.51
10.5
3 years 1.51
Extreme 1.51
25
5 years 1.51
Extreme 1.51
32.6
10 years 1.51
Extreme 1.51
32.6
Manager TitleAgeSince
Chief Executive Officer 48 2019-08-31
Director of Finance/CFO 36 2021-05-09
Chief Tech/Sci/R&D Officer 42 2020-01-09
Director TitleAgeSince
Director/Board Member 48 2020-05-11
Chairman 63 2019-08-22
Director/Board Member 36 2022-11-14
Date Insider Type Main position Quantity % Market Cap. Importance
10/15/24 Other

Founder

15,000 0.0049%
10/3/24 Other

Chief Financial Officer

20,000 0.0066%
10/2/24 Other

Chief Financial Officer

30,000 0.0098%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-8.31%-84.39%-92.74% 74.13M
-0.65%-2.93%+47.70%+86.17% 994B
-0.29%-3.51%+49.15%+62.35% 640B
+0.83%+0.26%+17.76%+72.25% 454B
-0.38%-3.59%+30.13%+35.17% 337B
-0.09%-13.54%+13.34%+24.95% 261B
-0.43%-2.48%-0.73%+9.58% 246B
-1.34%-13.70%+36.53%+44.96% 204B
-3.44%-7.51%-20.63%-59.44% 190B
-0.75%-4.82%+25.46%+87.14% 178B
Average -0.65%-6.01%+11.43%+27.04% 350.48B
Weighted average by Cap. -0.51%-4.42%+30.96%+54.94%

Financials

2026 *2027 *
Net sales 646M 755M 96.29M 83.3M 78.83M 71.43M 134M 9.2B 134M 936M 360M 4.7B 361M 354M 14.79B 1.18B 1.38B 176M 152M 144M 130M 244M 16.8B 246M 1.71B 657M 8.59B 660M 646M 27.01B
Net income -146M -170M -21.73M -18.79M -17.79M -16.12M -30.13M -2.08B -30.33M -211M -81.19M -1.06B -81.56M -79.79M -3.34B 44.25M 51.73M 6.6M 5.71M 5.4M 4.89M 9.15M 630M 9.21M 64.15M 24.65M 322M 24.76M 24.23M 1.01B
Net Debt 68.7M 80.32M 10.24M 8.86M 8.38M 7.6M 14.21M 979M 14.3M 99.6M 38.27M 500M 38.45M 37.61M 1.57B 136K 159K 20.28K 17.55K 16.61K 15.05K 28.13K 1.94M 28.31K 197K 75.8K 990K 76.14K 74.49K 3.11M
Logo Cutia Therapeutics
Cutia Therapeutics is an investment holding company principally engaged in the dermatology biopharmaceutical business. The Company is dedicated to developing solutions in the dermatology treatment and care market, including scalp diseases and care, skin diseases and care, topical anesthesia and localized adipose accumulation management. The Company is primarily engaged in the distribution of scalp diseases and care products, as well as certain skin care products. The Company's principal pipeline products include topical finasteride spray CU-40102, topical 4% minocycline foam CU-10201, topical novel small molecule agent CU-10101, localized topical lidocaine and tetracaine cream CU-30101 and recombinant mutant collagenase CU-20401.
Employees
268
Date Price Change Volume
26-09-11 HK$1.600 0.00% 188,000
26-09-10 HK$1.600 -2.14% 117,400
26-09-09 HK$1.635 -3.54% 50,400
26-09-08 HK$1.695 -0.29% 8,800
26-09-07 HK$1.700 -2.58% 255,000
Trader
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1.369CNY
Average target price
9.702CNY
Spread / Average Target
+608.85%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 2487 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!